NASDAQ:LFWD - Nasdaq - IL0011331076 - Common Stock - Currency: USD
1.1
-0.04 (-3.51%)
The current stock price of LFWD is 1.1 USD. In the past month the price decreased by -14.73%. In the past year, price decreased by -75.45%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.37 | 235.96B | ||
ISRG | INTUITIVE SURGICAL INC | 67.04 | 183.58B | ||
BSX | BOSTON SCIENTIFIC CORP | 36.94 | 147.56B | ||
SYK | STRYKER CORP | 30.11 | 144.19B | ||
MDT | MEDTRONIC PLC | 15.87 | 111.93B | ||
BDX | BECTON DICKINSON AND CO | 12.22 | 49.36B | ||
EW | EDWARDS LIFESCIENCES CORP | 28.9 | 44.08B | ||
IDXX | IDEXX LABORATORIES INC | 45.85 | 42.36B | ||
RMD | RESMED INC | 27.46 | 36.56B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.71 | 33.08B | ||
DXCM | DEXCOM INC | 49.69 | 32.15B | ||
STE | STERIS PLC | 25.84 | 23.71B |
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The firm offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The firm offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
LIFEWARD LTD
3 Hatnufa st. 6th fl., P.O. Box 161
Yokneam IL
Employees: 80
Phone: 97249590123
The current stock price of LFWD is 1.1 USD. The price decreased by -3.51% in the last trading session.
The exchange symbol of LIFEWARD LTD is LFWD and it is listed on the Nasdaq exchange.
LFWD stock is listed on the Nasdaq exchange.
9 analysts have analysed LFWD and the average price target is 6.63 USD. This implies a price increase of 502.73% is expected in the next year compared to the current price of 1.1. Check the LIFEWARD LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LIFEWARD LTD (LFWD) has a market capitalization of 12.11M USD. This makes LFWD a Nano Cap stock.
LIFEWARD LTD (LFWD) currently has 80 employees.
LIFEWARD LTD (LFWD) has a resistance level at 1.22. Check the full technical report for a detailed analysis of LFWD support and resistance levels.
The Revenue of LIFEWARD LTD (LFWD) is expected to grow by 10.08% in the next year. Check the estimates tab for more information on the LFWD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LFWD does not pay a dividend.
LIFEWARD LTD (LFWD) will report earnings on 2025-08-13.
LIFEWARD LTD (LFWD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.93).
The outstanding short interest for LIFEWARD LTD (LFWD) is 3.15% of its float. Check the ownership tab for more information on the LFWD short interest.
ChartMill assigns a fundamental rating of 3 / 10 to LFWD. The financial health of LFWD is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months LFWD reported a non-GAAP Earnings per Share(EPS) of -1.93. The EPS increased by 37.94% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -95.46% | ||
ROE | -149% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 82% to LFWD. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 52.94% and a revenue growth 10.08% for LFWD